BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 38534327)

  • 1. Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells.
    Sidorova TN; Yermalitskaya LV; Mace LC; Wells KS; Boutaud O; Prinsen JK; Davies SS; Roberts LJ; Dikalov SI; Glabe CG; Amarnath V; Barnett JV; Murray KT
    J Mol Cell Cardiol; 2015 Feb; 79():295-302. PubMed ID: 25463275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of isolevuglandin-modified protein in normal and fibrotic lung.
    Mont S; Davies SS; Roberts Second LJ; Mernaugh RL; McDonald WH; Segal BH; Zackert W; Kropski JA; Blackwell TS; Sekhar KR; Galligan JJ; Massion PP; Marnett LJ; Travis EL; Freeman ML
    Sci Rep; 2016 Apr; 6():24919. PubMed ID: 27118599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
    Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
    Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
    Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension.
    Prinsen JK; Kannankeril PJ; Sidorova TN; Yermalitskaya LV; Boutaud O; Zagol-Ikapitte I; Barnett JV; Murphy MB; Subati T; Stark JM; Christopher IL; Jafarian-Kerman SR; Saleh MA; Norlander AE; Loperena R; Atkinson JB; Fogo AB; Luther JM; Amarnath V; Davies SS; Kirabo A; Madhur MS; Harrison DG; Murray KT
    JACC Basic Transl Sci; 2020 Jun; 5(6):602-615. PubMed ID: 32613146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device.
    O'Neill MJ; Yoneda ZT; Crawford DM; Ye F; Ao M; Pitchford LM; Rathmacher JA; Murray KT; Akers WS; Roden DM; Michaud GF; Shoemaker MB
    Trials; 2021 Aug; 22(1):576. PubMed ID: 34454591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
    Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
    Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
    Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG
    Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic Peptide Oligomers Cause Proarrhythmic Metabolic and Electrophysiological Effects in Atrial Myocytes.
    Yang Z; Subati T; Kim K; Murphy MB; Dougherty OP; Christopher IL; Van Amburg JC; Woodall KK; Barnett JV; Murray KT
    Circ Arrhythm Electrophysiol; 2022 Mar; 15(3):e010636. PubMed ID: 35212578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress.
    Avula UMR; Dridi H; Chen BX; Yuan Q; Katchman AN; Reiken SR; Desai AD; Parsons S; Baksh H; Ma E; Dasrat P; Ji R; Lin Y; Sison C; Lederer WJ; Joca HC; Ward CW; Greiser M; Marks AR; Marx SO; Wan EY
    JCI Insight; 2021 Oct; 6(23):. PubMed ID: 34710060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Mitochondrial Dysfunction in Atrial Fibrillation: Translation to Druggable Target and Biomarker Discovery.
    Pool L; Wijdeveld LFJM; de Groot NMS; Brundel BJJM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction in Atrial Fibrillation-Mechanisms and Pharmacological Interventions.
    Muszyński P; Bonda TA
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34071563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunction Contributes to Aging-Related Atrial Fibrillation.
    Liu C; Bai J; Dan Q; Yang X; Lin K; Fu Z; Lu X; Xie X; Liu J; Fan L; Li Y
    Oxid Med Cell Longev; 2021; 2021():5530293. PubMed ID: 34007402
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.